再灌流性心律失常的临床探讨  

Clinical Evaluation of Reperfusion Arrhythmia.

作　　者：王学忠[1] 齐晓勇[1] 甄胜西[1] 康母依[1] 徐力飞[1] 韩玉平[1] 赵兰辉[2] 蔡文训 王瑞肖 

机构地区：[1]河北省医院,石家庄050051 [2]河北医学院,石家庄050017

出　　处：《急诊医学》1993年第1期10-12,37,共4页

摘　　要：本文分析了急性心肌梗死622例中有 Q 及非 Q 波的 ST 段抬高>2mm 者187例用血管扩张剂及溶栓疗法后,符合冠脉再通的指标108例,分与三组观察其再灌流性心律失常的发生率。结果表明,A 组用血管扩张剂,再灌流心律失常(RA)发生率为71%(12/21);B 组用蝮蛇抗栓酶溶栓者,RA 发生率为81%(45/58);C 组用尿激酶溶栓者,RA 发生率为86%(25/29)。A 组 RA 发生率明显低于 B、C 两组(P<0.01);后两组间无显著差异(P>0.05)。提示 B、C 两组 RA 发生率高于 A 组。本文对 RA 的诊断和防治问题加以探讨。One hundred and eighty seven cases in 622 cases of acute myocardial infarction with Q wave infarction,or non-Q wave infarction and S—T segment elevated more than 2 mm were analyzed. The incidence of reperfusion arrhythmia was observed in 108 cases according with the criteria of recanalization following vasodilator and thrombolytic therapy。The results showed that 71%(12/ 21)of reperfusion arrhythmia occurred in group A treated with vasodilator,81%(45/58)in group B treated with agkistrodon haiys,and 86%(25/29)in group C treated with streptokinase.It was suggested that the incidence of reperfusion arrhythmia in group B and C was significantly higher than that in group A (P<0.01),there were no significant differences between group B and C(P >0.05).The diagnosis and treatment of reperfusion arrhythmia were also investigated in this study.

关 键 词：急性 心律失常 溶栓治疗 再灌注损伤 心肌梗塞 

分 类 号：R542.220.5[医药卫生—心血管疾病] R541.7[医药卫生—内科学]